Halaman 3 - Kanker hati stadium 4 Dokter Terbaik - TOP-87 dokter

Lebih dari 28 tahun berspesialisasi dalam kanker hati dan pankreas – Dr. Ben-haim adalah salah satu ahli bedah onkologi gastrointestinal terkemuka di Israel di Sourasky Medical Center.

• Ahli dalam operasi Whipple untuk kasus-kasus kompleks
• Berfokus secara eksklusif pada kanker gastrointestinal
• Melakukan intervensi lanjutan untuk manajemen kanker

Prof. Wolfgang Köstler berspesialisasi dalam terapi kanker terarah, dengan fokus pada keganasan payudara dan ginekologi. Beliau menggabungkan pengalaman klinis selama puluhan tahun dengan penelitian mutakhir.

• Berpengalaman lebih dari 20 tahun di bidang onkologi medis
• Ahli dalam pengobatan kanker personal dan imunoterapi
• Konsultan senior di Wiener Privatklinik
• Professor Madya di Universitas Kedokteran Wina
• Penelitian yang diterbitkan mengenai pengembangan biomarker dan biologi tumor

Associate Professor Dr. Yusuf Acikgoz membawa pengalaman onkologi internasional dari Ohio State University ke Lokman Hekim University Ankara Hospital.

• Spesialisasi dalam Onkologi Medis dengan pelatihan ekstensif di Turki dan AS
• Berpartisipasi dalam uji klinis Fase III untuk pengobatan kanker stadium lanjut
• Anggota American Society of Clinical Oncology (ASCO)
• Sertifikasi dalam Good Clinical Practice dan penelitian subjek manusia

Associated Professor Tahsin Ozatli spesialis dalam kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Lebih dari 15 tahun pengalaman di bidang onkologi
• Spesialis Penyakit Dalam di Rumah Sakit Umum Malatya
• Bertugas di Klinik Onkologi Ankara dan Rumah Sakit Pelatihan Regional Erzurum
• Menempuh pendidikan kedokteran di Universitas Selcuk

Dr. Liuying leads the Oncology Ward at Jinshazhou Hospital, Guangzhou University of Chinese Medicine. Clinical focus includes hepatocellular carcinoma, cholangiocarcinoma, and lung and colorectal cancers. Dr. Liuying has special expertise in melanoma and melanoma liver metastasis. Interventional skills include MWA, RFA, cryoablation, and radioactive seed implantation for non-vascular, minimally invasive tumor ablation.

Research: participated in two Guangdong Provincial science and technology projects. Contributed to the 2014 Expert Consensus for Thermal Ablation of Primary and Metastatic Lung Tumors. Published in the Chinese Journal of Lung Cancer. Compiled Selected Cases of Microwave Ablation for Lung Tumors and Selected Cases of Microwave Ablation for Liver Tumors.

Appointments: Standing Committee Member, Youth Committee of Intra-Tumor Brachytherapy Medicine, China Medical Education Association. Standing Committee Member, Minimally Invasive Interventional Medicine Professional Committee, Guangdong Primary Medical Association.

Kepala Pusat Kanker Gastrointestinal di Hadassah Medical Center – mengawasi langsung kasus kanker hati yang kompleks. Karier selama 33 tahun sepenuhnya berfokus pada onkologi dan radioterapi.

• Sertifikasi dewan dalam onkologi medis dan radioterapi
• Menjalani pelatihan dan membangun karier di Rumah Sakit Universitas Hadassah di Yerusalem
• Anggota aktif Komite Nasional Kanker Gastrointestinal
• Berpengalaman dalam terapi sistemik terbaru dan radiasi terarah
• Peran dokter senior yang terlibat dalam pelatihan onkolog lainnya

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Profesor Gul Alco adalah spesialis onkologi radiasi di Medipol Acibadem District Hospital, dengan pengalaman lebih dari 20 tahun di bidang tersebut.

• Profesor di Departemen Onkologi Radiasi Universitas Medipol Istanbul
• Menyelesaikan residensi di Fakultas Kedokteran Universitas Kadir Has
• Lektor Kepala dan kemudian Profesor di Universitas Demiroglu Bilim
• Bekerja di Rumah Sakit Şişli Florence Nightingale dan Rumah Sakit Gayrettepe Florence Nightingale

Nail Paksoy membawa pengalaman luas dari Institut Onkologi Universitas Istanbul dan sekarang menjabat sebagai Lektor Kepala di Rumah Sakit Medipol Bahçelievler.

• Spesialisasi dalam pengobatan kanker hati dengan fokus pada stadium lanjut
• Sertifikasi dewan dalam Onkologi Medis oleh ESMO
• Berkontribusi pada delapan uji klinis internasional di bidang onkologi
• Menerbitkan berbagai makalah penelitian tentang kanker metastatik

Spesialis dalam bedah laparoskopi tingkat lanjut dan onkologi – Dr. Al membawa pelatihan ekstensif dari institusi medis terkemuka di Turki.

• Menjalani pelatihan di Fakultas Kedokteran Cerrahpaşa Universitas Istanbul
• Keahlian dalam teknik bariatrik laparoskopi dan anti-refluks
• Pengalaman bedah lebih dari 30 tahun

Spesialis dalam bedah kanker hati invasif minimal di Rumah Sakit Medical Park Goztepe, berfokus pada pengurangan waktu pemulihan pasien.

• Penulis lebih dari 40 dokumen medis
• Anggota fakultas di Fakultas Kedokteran Universitas Bahçeşehir
• Anggota American College of Surgeons yang bergengsi
• Juga anggota Liver Transplantation Society
• Menempuh pendidikan di Universitas Cukurova dan Ege

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

30+ tahun di bidang imunologi dengan fokus pada viroterapi – Dr. Jaunalksne berspesialisasi dalam perawatan imunologi mutakhir untuk kanker hati di Pallas Clinic.

• Memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Menempuh pendidikan di Institut Medis Riga dan menyelesaikan magang Penyakit Dalam
• Berfokus pada viroterapi, sebuah pendekatan baru dalam pengobatan kanker

Spesialisasi dalam bedah kanker kompleks, termasuk prosedur hati, pankreas, dan saluran empedu di Rumah Sakit Büyük Anadolu.

• Ahli dalam bedah onkologi dengan fokus pada kanker gastrointestinal
• Melakukan bedah bariatrik dan metabolik tingkat lanjut
• Terampil dalam operasi kanker payudara dan tiroid

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.